Urinary cotinine levels of electronic cigarette (e-cigarette) users

Toxicology Mechanisms and Methods

Volumn 26, Issue 6, 2016, Pages 414-418

  Göney, Gülşen ^a   Çok, İsmet ^a   Tamer, Uğur ^b   Burgaz, Sema ^a   Şengezer, Tijen ^c  

^a GAZI UNIVERSITY   (Turkey)

^b Minister of Health ^*  (Turkey)

^c Minister of Health   (Turkey)

Author keywords

Cotinine; e cigarette; GC MS; Turkey; urine

Indexed keywords

COTININE; CREATININE; NICOTINE; BIOLOGICAL MARKER; PASSIVE SMOKING;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; ELECTRONIC CIGARETTE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; PASSIVE SMOKING; PRIORITY JOURNAL; SMOKING; URINALYSIS; URINARY EXCRETION; ADULT; ADVERSE EFFECTS; ANALYSIS; CASE CONTROL STUDY; QUESTIONNAIRE; URINE;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; COTININE; CREATININE; ELECTRONIC CIGARETTES; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; NICOTINE; SMOKING; SURVEYS AND QUESTIONNAIRES; TOBACCO SMOKE POLLUTION;

EID: 84973662128     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2016.1144127     Document Type: Article

References (32)

1. S.E.Adkison, R.J.O’Connor, M.Bansal-Travers,. (2013). Electronic nicotine delivery systems:ınternational tobacco control four-country survey. Am J Prev Med 44:207–15
2. N.L.Benowitz (1996). Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 18:188–204
3. C.Bullen, H.McRobbie, S.Thornley,. (2010). Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery:randomised cross-over trial. Tob Control 19:98–103
4. N.Brajenović, I.B.Karačonji, A.Bulog (2015). Evaluation of urinary btex, nicotine, and cotinine as biomarkers of airborne pollutants in nonsmokers and smokers. J Toxicol Environ Health A 78:1133–6
5. D.R.Camenga, J.Delmerico, G.Kong,. (2014). Trends in use of electronic nicotine delivery systems by adolescents. Addict Behav 39:338–40
6. P.Caponnetto, D.Campagna, F.Cibella,. (2013). Efficiency and safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute:a prospective 12-month randomized control design study. PLoS One 8:e66317
7. N.P.Cheah, N.W.L.Chong, J.Tan,. (2014). Electronic nicotine delivery systems:regulatory and safety challenges:Singapore perspective. Tob Control 23:115–25
8. M.Curvall, E.K.Vala, C.R.Enzell,. (1990). Simulation and evaluation of nicotine intake during passive smoking:cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine. Clin Pharmacol Ther 47:42–9
9. I.Cok, R.Ozturk (2000). Urinary cotinine levels of smokeless tobacco (Maraş powder) users. Hum Exp Toxicol 19:650–5
10. L.Dawkins, O.Corcoran (2014). Acute electronic cigarette use:nicotine delivery and subjective effects in regular users. Psychopharmacology 231:401–7
11. T.Eissenberg (2010). Electronic nicotine delivery devices:ineffective nicotine delivery and craving suppression after acute administration. Tob Control 19:87–8
12. J.F.Etter, C.Bullen (2011a). Electronic cigarette:users profile, utilization, satisfaction and perceived efficacy. Addiction 106:2017–28
13. J.F.Etter, C.Bullen (2011b). Saliva cotinine levels in users of electronic cigarettes. Eur Respir J 38:1219–20
14. J.F.Etter (2014). Levels of saliva cotinine in electronic cigarette users. Addiction 109:825–9
15. FDA. (2009). U.S. Food and Drug Administration. Family Smoking Prevention and Tobacco Control Act. Available from:http://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm246129.htm [last accessed 9 Jan 2016]
16. FDA. (2016). U.S. Food and Drug Administration. Deeming – Extending Authorities to Additional Tobacco Products. Available from:http://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm388395.htm [last accessed 9 Jan 2016]
17. S.Fischer, B.Spiegelhalder, R.Preussmann (1991). Tobacco-specific nitrosamines in commercial cigarettes:possibilities for reducing exposure. IARC Sci Publ 105:489–92
18. A.D.Flouris, M.S.Chorti, K.P.Poulianiti,. (2013). Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25:91–101
19. M.L.Goniewicz, T.Kuma, M.Gawron,. (2013). Nicotine levels in electronic cigarettes. Nicotine Tob Res 15:158–66
20. V.Haufroid, D.Lison (1998). Urinary cotinine as a tobacco-smoke exposure index:a minireview. Int Arch Occup Environ Health 71:162–8
21. K.Hammond (2004). Global patterns of nicotine and tobacco consuption. In:J.Henningfield, E.London, S.Pogun, eds. Nicotine psychopharmacology. München:Springer, 3–28
22. J.A.Lutsgarten, E.R.Wenk (1972). Simple, rapid, kinetic method for serum creatinine measurement. Clin Chem 18:1419–22
23. C.N.Man, L.H.Gam, S.Ismail,. (2006). Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography–mass spectrometry. – spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 844:322–7
24. A.M.Massadeh, A.A.Gharaibeh, K.W.Omari (2009). A single-step extraction method for the determination of nicotine and cotinine in Jordanian smokers’ blood and urine samples by RP-HPLC and GC–MS. J Chromatogr Sci 47:170–7
25. S.N.Miller, J.A.Cocores (1993). Nicotine dependence:diagnosis, chemistry, and pharmacologic treatments. Pediatr Rev 14:275–9
26. T.Pagano, M.R.Bida, R.J.Robinson (2015). Laboratory activity for the determination of nicotine in electronic cigarette liquids using gas chromatography–mass spectrometry. J Lab Chem Educ 3:37–43
27. A.R.Vansickel, C.O.Cobb, M.F.Weaver,. (2010). A clinical laboratory model for evaluating the acute effects of electronic “cigarettes”:nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 19:1945–53
28. A.R.Vansickel, T.Eissenberg (2013). Electronic cigarettes:effective nicotine delivery after acute administration. Nicotine Tob Res 15:267–70
29. A.R.Vansickel, M.F.Weaver, T.Eissenberg (2012). Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction 107:1493–500
30. K.A.Vickerman, K.M.Carpenter, T.Altman,. (2013). Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res 15:1787–91
31. B.J.Westenberger (2009). Evaluation of e-cigarettes. St Louis, MO:Department of Health and Human Services Food and Drug Administration. Available from:http://www.fda.gov/downloads/Drugs/ScienceResearch/UCM173250.pdf. [last accessed 8 Nov 2015]
32. S.H.Zhu, J.Y.Sun, E.Bonnevie,. (2014). Four hundred and sixty brands of e-cigarettes and counting:implications for product regulation. Tob Control 23:iii3–9